Stada Arzneimittel AG (SAZ):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Stada Arzneimittel AG (SAZ) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7190
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers a portfolio of products in various therapeutic categories including pain, women’s health, cardiovascular conditions and diabetes. Few of its major generic products include including Tilidin Naloxon, Atorvastatin, Pantoprazol, Epoetin zeta and Diclofenac. Its major branded products include APO-Go, Grippostad, Snup, Fultium, and Vitaprost. The company operates in more than 30 countries with sales in Germany, Central Europe, CIS/Eastern Europe and Asia-Pacific. STADA is headquartered in Bad Vilbel, Germany.

Stada Arzneimittel AG (SAZ) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stada Arzneimittel AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stada Arzneimittel AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stada Arzneimittel AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stada Arzneimittel AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Stada Arzneimittel AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stada Arzneimittel AG, Medical Equipment, Deal Details 10
Private Equity 10
Bain Capital and Cinven Partners to Acquire Stada Arzneimittel 10
Partnerships 12
3M Enters Into Licensing Agreement With Stada For Fentanyl Transdermal Patch Technology 12
Lophius Biosciences Enters into Agreement with BL&H 13
Vigilant Biosciences Enters into Distribution Agreement with BL&H 14
Acquisition 15
Nidda Healthcare to Acquire Stake in Stada Arzneimittel 15
STADA Arzneimittel Acquires SCIOTEC Diagnostic Technologies for USD19.8 Million 16
Stada Arzneimittel AG – Key Competitors 17
Stada Arzneimittel AG – Key Employees 18
Stada Arzneimittel AG – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 22
Financial Announcements 22
Aug 09, 2018: STADA’s business development in the first six months of 2018 as expected 22
May 03, 2018: STADA with solid business development in the first quarter of 2018 24
Mar 08, 2018: STADA records positive business development in 2017 26
Nov 09, 2017: STADA shows good business development in the third quarter of 2017 and the first nine months 29
Corporate Communications 31
Sep 03, 2018: Peter Goldschmidt to succeed Claudio Albrecht as STADA’s CEO 31
Apr 16, 2018: Changes in the management team of STADA 32
Feb 01, 2018: Supervisory Board of STADA Arzneimittel appoints Peter Goldschmidt as new Chairman of the Executive Board as of September 1, 2018 33
Feb 01, 2018: Peter Goldschmidt to succeed Claudio Albrecht as CEO on 1 September 2018 34
Jul 04, 2017: STADA Arzneimittel appoints new Chief Executive Officer and Chief Financial Officer – incumbents step down from their positions 35
Apr 24, 2017: Dr. Ralph Grobecker to become Managing Director of STADA’s OTC segment 36
Other Significant Developments 37
Sep 12, 2018: STADA invites the holders of the STADA Bond to participate in the bondholders meeting and to vote in favor of the proposed resolutions 37
Aug 03, 2017: STADA shows good operational development in first six months of 2017 38
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Stada Arzneimittel AG, Medical Equipment, Key Facts, 2017 2
Stada Arzneimittel AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stada Arzneimittel AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stada Arzneimittel AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stada Arzneimittel AG, Deals By Market, 2012 to YTD 2018 8
Stada Arzneimittel AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bain Capital and Cinven Partners to Acquire Stada Arzneimittel 10
3M Enters Into Licensing Agreement With Stada For Fentanyl Transdermal Patch Technology 12
Lophius Biosciences Enters into Agreement with BL&H 13
Vigilant Biosciences Enters into Distribution Agreement with BL&H 14
Nidda Healthcare to Acquire Stake in Stada Arzneimittel 15
STADA Arzneimittel Acquires SCIOTEC Diagnostic Technologies for USD19.8 Million 16
Stada Arzneimittel AG, Key Competitors 17
Stada Arzneimittel AG, Key Employees 18
Stada Arzneimittel AG, Subsidiaries 19

List of Figures
Stada Arzneimittel AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stada Arzneimittel AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Stada Arzneimittel AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stada Arzneimittel AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Stada Arzneimittel AG (SAZ):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Whirlpool Of India Limited:企業の戦略・SWOT・財務情報
    Whirlpool Of India Limited - Strategy, SWOT and Corporate Finance Report Summary Whirlpool Of India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Progress Software Corp (PRGS):企業の財務・戦略的SWOT分析
    Progress Software Corp (PRGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • University of Cambridge-医療機器分野:企業M&A・提携分析
    Summary University of Cambridge (UC) is an educational and research institute that offers undergraduate and graduate studies. The institute offers undergraduate courses in areas of architecture, chemical engineering, classics, computer science. It provides courses such as economics, education, engin …
  • Shree Renuka Sugars Ltd (RENUKA):企業の財務・戦略的SWOT分析
    Shree Renuka Sugars Ltd (RENUKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • EWE AG:企業の戦略的SWOT分析
    EWE AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Enlight Renewable Energy Ltd (ENLT):企業の財務・戦略的SWOT分析
    Summary Enlight Renewable Energy Ltd (Enlight Renewable) is a renewable energy company that invests, develops, finances, constructs, operates and manages electricity production projects from renewable energy sources. The company develops photovoltaic technology by which solar energy is converted to …
  • Oriental Food Industries Holdings Berhad:企業の戦略・SWOT・財務情報
    Oriental Food Industries Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Oriental Food Industries Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Cantel Medical Corp (CMD):医療機器:M&Aディール及び事業提携情報
    Summary Cantel Medical Corp (Cantel) is a provider of infection prevention and control products and services for the healthcare market. Its product portfolio includes endoscopy procedure disposables, medical device reprocessing systems, detergents, disinfectants, water purification systems, filtrati …
  • CITIC Securities Company Limited:戦略・SWOT・企業財務分析
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Gold Fields Ltd:戦略・SWOT・企業財務分析
    Gold Fields Ltd - Strategy, SWOT and Corporate Finance Report Summary Gold Fields Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • OJSC Dixy Group:企業の戦略・SWOT・財務情報
    OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report Summary OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cognition Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cognition Therapeutics Inc (CogRx) is a drug discovery and development company that discovers and develops small molecule therapeutics. The company uses its proprietary biology and chemistry platforms for the development of novel drug targets and disease modifying therapies for the treatment …
  • SRF Ltd (SRF):企業の財務・戦略的SWOT分析
    SRF Ltd (SRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • A. Menarini Industrie Farmaceutiche Riunite Srl:企業の戦略的SWOT分析
    A. Menarini Industrie Farmaceutiche Riunite Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • PT Tigaraksa Satria Tbk (TGKA):企業の財務・戦略的SWOT分析
    PT Tigaraksa Satria Tbk (TGKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Avgol Industries 1953 Ltd. (AVGL):企業の財務・戦略的SWOT分析
    Avgol Industries 1953 Ltd. (AVGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • SFS Group AG:企業の戦略・SWOT・財務情報
    SFS Group AG - Strategy, SWOT and Corporate Finance Report Summary SFS Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Petroleum Company of Trinidad and Tobago Ltd:企業の戦略的SWOT分析
    Petroleum Company of Trinidad and Tobago Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Whatabrands LLC:企業の戦略・SWOT・財務情報
    Whatabrands LLC - Strategy, SWOT and Corporate Finance Report Summary Whatabrands LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Decas Cranberry Products, Inc.:企業の戦略・SWOT・財務情報
    Decas Cranberry Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Decas Cranberry Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆